---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-013845"
form_type: "8-K"
ticker: "CVSA"
cik: "0000730464"
company_name: "Covista Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:29:05.625937+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Adtalem Q1 FY2025: Revenue up 13.2%, adj. EPS $1.29 (+38.7% YoY); raises FY guidance

## Summary
- Revenue $417.4M (+13.2% YoY); net income $46.2M vs $10.6M prior year; adj. EPS $1.29 vs $0.93.
- Total enrollment 90,140, up 11.2% YoY; Chamberlain +11.7%, Walden +12.2%, Medical/Vet -0.7%.
- FY2025 guidance raised: revenue $1,690M-$1,730M; adj. EPS $5.75-$5.95 (14.5%-18.5% growth).
- Repurchased $34M of shares; $178M remaining under $300M buyback program through Jan 2027.
- Repriced $253M Term Loan B, reducing interest rate by 75 bps; net leverage 1.0x.

## SEC filing metadata
- accession: 0001558370-24-013845
- form_type: 8-K
- ticker: CVSA
- cik: 0000730464
- company_name: Covista Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730464/000155837024013845/0001558370-24-013845-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730464/000155837024013845/atge-20241029x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-013845
- JSON: https://secwatch.observer/filing/0001558370-24-013845.json
- Plain text: https://secwatch.observer/filing/0001558370-24-013845.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.